Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cecilia Graffman"'
Autor:
Anna-Maria Larsson, Sara Jansson, Pär-Ola Bendahl, Charlotte Levin Tykjaer Jörgensen, Niklas Loman, Cecilia Graffman, Lotta Lundgren, Kristina Aaltonen, Lisa Rydén
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-14 (2018)
Abstract Background Circulating tumor cells (CTCs) carry independent prognostic information in patients with metastatic breast cancer (MBC) on different lines of therapy. Moreover, CTC clusters are suggested to add prognostic information to CTC enume
Externí odkaz:
https://doaj.org/article/c2c46fbf1e944a7a9bb4464938ecf6b7
Autor:
Niklas Loman, Sara Jansson, Lisa Rydén, Anna Maria Larsson, Lotta Lundgren, Charlotte Jørgensen, Pär-Ola Bendahl, Cecilia Graffman, Kristina Aaltonen
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-14 (2018)
Background Circulating tumor cells (CTCs) carry independent prognostic information in patients with metastatic breast cancer (MBC) on different lines of therapy. Moreover, CTC clusters are suggested to add prognostic information to CTC enumeration al
Autor:
Pär-Ola Bendahl, Kristina Aaltonen, Lisa Rydén, Anna Maria Larsson, Cecilia Graffman, Vendula Novosadova
Publikováno v:
Oncotarget
Resistance to systemic therapy is a major problem in metastatic breast cancer (MBC) that can be explained by initial tumor heterogeneity as well as by evolutionary changes during therapy and tumor progression. Circulating tumor cells (CTCs) detected
Autor:
Sara Jansson, Lisa Rydén, Sharyn D. Baker, Niklas Loman, P-O Bendahl, A-M Larsson, Christine Lundgren, Kristina Aaltonen, Cecilia Graffman
Publikováno v:
Cancer Research. 78:P2-01
Background: Detection and enumeration of circulating tumor cells (CTCs) allows real time monitoring of disease evolvement. In women with metastatic breast cancer (MBC), a CTC count of ≥5 CTCs is associated with decreased progression-free survival (
Publikováno v:
Blood. 126:3939-3939
Rationale: The anticonvulsant valproate is an HDAC inhibitor, which has in vitro been shown to sensitize lymphoma cell lines for CHOP chemotherapy, and to upregulate CD20 expression. Based on these findings, we initiated a dose finding trial of valpr
Publikováno v:
Annals of Oncology. 26:iii15
Introduction: Detection of circulating tumour cells (CTCs) in peripheral blood has an established prognostic significance in patients with metastatic breast cancer. Change in the number of detected CTCs is also an indication of response to therapy. C